AmbioPharm - A Global Peptide CDMO

AmbioPharm - A Global Peptide CDMO

制药业

North Augusta,SC 5,942 位关注者

Global Peptide Contract Development & Manufacturing Organization (CDMO).

关于我们

AmbioPharm, a global peptide CDMO, was founded in 2005 and is headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at small to very large scales. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA with excellent outcomes.

网站
https://www.ambiopharm.com
所属行业
制药业
规模
501-1,000 人
总部
North Augusta,SC
类型
私人持股
创立
2005
领域
NCEs、Cosmetic Peptides、GMP Peptides、Peptides、Custom Peptide Synthesis、Peptide Active Pharmaceutical Ingredients (APIs)、NCE peptides、Preclinical Manufacturing、Process Development、Analytical Methods Support、Regulatory Support、Commercial Peptide Manufacturing、GMP Peptide Manufacturing、 Peptide Contract Development & Manufacturing Organization (CDMO)、Clinical Peptides、Agricultural peptides、Peptide API Manufacturing、Clinical Grade Peptide Manufacturing、Peptide Manufacturing和FDA Inspected

地点

  • 主要

    1024 Dittman Court

    US,SC,North Augusta,29842

    获取路线
  • No.399, Yingong Road, Fengxian Sub-zone

    Shanghai Chemical Industry Park

    CN, Shanghai

    获取路线

AmbioPharm - A Global Peptide CDMO员工

动态

相似主页

融资